Research Overview: ARIMIMED 1 DEUS MEDICAL
ARIMIMED 1 DEUS MEDICAL is an aromatase inhibitor research compound formulated for laboratory studies investigating hormone regulation pathways. Each tablet contains 1mg of anastrozole, a selective non-steroidal aromatase inhibitor that enables researchers to examine estrogen synthesis suppression in controlled experimental environments. This pharmaceutical-grade compound allows scientific investigators to study aromatase enzyme interactions and hormonal balance mechanisms. Leading researchers from Stroid UK Shop utilise this compound alongside other research materials to advance understanding of endocrine system modulation.
Laboratory Applications
Research scientists employ ARIMIMED 1 to investigate aromatase enzyme inhibition in various experimental protocols. Studies focus on examining how anastrozole blocks the conversion of androgens to estrogens at the molecular level. Laboratory applications include analysing hormone-dependent cellular processes, investigating receptor binding mechanisms, and evaluating enzymatic pathway disruption. Researchers studying anastrozol estrogen blockers frequently combine this compound with other research chemicals to examine synergistic effects. Advanced studies incorporate ARIMIMED 1 alongside SARMs and peptides to investigate comprehensive hormonal modulation pathways in controlled laboratory settings.
Technical Specifications
| Active Compound | Anastrozole |
|---|---|
| Concentration | 1mg per tablet |
| Form | Oral tablets |
| CAS Number | 120511-73-1 |
| Molecular Formula | C17H19N5 |
| Molecular Weight | 293.37 g/mol |
| Storage | Room temperature, dry conditions |
| Shelf Life | 24 months sealed |
Research Compliance
ARIMIMED 1 DEUS MEDICAL is manufactured exclusively for in-vitro research applications and scientific investigation purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must possess appropriate qualifications and facilities to handle this compound safely. All studies should follow established laboratory protocols and safety guidelines for handling pharmaceutical research materials.
